Miguel Patricio & Albert Bourla Net Worth, Bio & Careers

Miguel Patricio and Albert Bourla have never shared an employer, a stage, or even a hometown. Yet their names keep turning up together — in CEO rankings, compensation studies, and conversations about the kind of men who end up running the world’s biggest companies.

Patricio is the Portuguese marketing man who spent two decades selling beer across three continents before taking the helm at Kraft Heinz. Bourla is the Greek veterinarian who joined Pfizer’s animal health division in 1993 and simply never left, rising to run the pharmaceutical giant behind the world’s first widely used COVID-19 vaccine.

Both men became chief executives in 2019. Both were handed jobs that looked nearly impossible. But their stories begin in very different places — one in Portugal and Brazil, the other in a Thessaloniki family shaped by the Holocaust. This is the full story: their early lives, their parallel climbs, and what each man is worth today.

Miguel Patricio: The Portuguese Kid Who Fell for Brazil

Miguel Patricio was born in Portugal in 1966 and grew up far from the boardrooms he would one day run. What set his story apart was an early pull toward Brazil — a Portuguese-speaking country on the other side of the Atlantic where he chose to study Business Administration at the Fundação Getulio Vargas in São Paulo.

That decision shaped everything. Brazil in those years was a proving ground for ambitious consumer-goods marketers, and Patricio threw himself into it. His first major employers read like a who’s who of the industry: Johnson & Johnson, the Coca-Cola Company, and Philip Morris, with stints across Latin America, New Jersey, and Georgia.

It was the beginning of a pattern that would define his entire working life. Patricio never stayed in one market for long. He learned products on one continent and sold them on another — a marketer who collected countries the way other executives collect titles.

Albert Bourla: A Holocaust Family’s Son in Thessaloniki

Albert Bourla was born on October 21, 1961, in Thessaloniki, Greece, into a Sephardic Jewish family whose story reads like a history lesson. Both of his parents were Holocaust survivors. According to Bourla’s own accounts, his mother was seconds away from execution by firing squad when she was spared after her non-Jewish brother-in-law paid a ransom to a Nazi official. His father happened to be outside the city’s Jewish ghetto when its inhabitants were rounded up for Auschwitz, and he went into hiding, never seeing his parents again.

Thessaloniki had once been one of the great centers of Sephardic Jewish life; after the war, almost nothing of it remained. Bourla grew up in the long shadow of that loss, and those who know him say it instilled a work ethic and a sense of mission that never left him. From childhood, he wanted to be a doctor — a healer — and after finishing high school in 1979, he enrolled at the Aristotle University of Thessaloniki.

He trained as a veterinarian there and went on to earn a Ph.D. in the Biotechnology of Reproduction. For several years he practiced as a vet in Greece, fascinated by animals and by the idea that technology could push the boundaries of science and medicine. Nothing in that picture suggested a future in corporate America — and certainly not at the top of a $200 billion pharmaceutical empire.

From Marketing Desks to the Corner Office: Patricio’s Climb

Patricio’s big break came in 1998, when he joined the Brazilian brewer Ambev. Within a year he was its chief marketing officer — a remarkably fast rise that caught the attention of the executives who would soon merge Ambev with Interbrew to form AB InBev, the largest brewer on the planet.

What followed was a two-decade masterclass in climbing. Patricio was put in charge of North America, then of Asia Pacific, where he rebuilt the China business around premium brands. Under his leadership, the region’s revenues grew from about $1 billion in 2008 to $2.7 billion by 2012, with Budweiser becoming the leading beer brand in China. Then, from 2012 to 2018, he served as AB InBev’s global chief marketing officer, running the playbook for Corona, Budweiser, and Stella Artois — a portfolio that generated more than a third of the company’s organic growth. In his final year, AB InBev was the most awarded brand owner at Cannes Lions.

By 2019, Kraft Heinz was in trouble. The packaged-food giant had slashed its dividend, written down the value of the Kraft and Oscar Mayer brands by more than $15 billion, and disclosed an SEC subpoena. The board wanted a brand-builder, not a cost-cutter — and Patricio, the 30-year marketing veteran, got the call. He took over as CEO on July 1, 2019, succeeding Bernardo Hees, and spent four years pushing marketing investment, company culture, and portfolio reform. He stepped down at the start of 2024 as part of a planned succession to Carlos Abrams-Rivera, moved into the chair’s role, and — after a brief stint as executive chair during a proposed company split — ended his chairmanship in December 2025. He remains on the boards of both Kraft Heinz and AB InBev.

The Veterinarian Who Never Left: Bourla’s Three Decades at Pfizer

Bourla’s route to the top could hardly have been more different. In 1993, at 32, he accepted a job as technical director of Pfizer’s animal health division in Greece — reportedly as a stopgap while he waited for a permanent academic position. The academic post never came, and the stopgap became a career.

He moved to New York in 2001 as a group marketing director, then ran animal health across Europe, Africa, and the Middle East. Gradually he crossed from animal health into human medicine: leading the established-products business from 2010 to 2013, then vaccines, oncology, and consumer healthcare, then — from 2016 to 2017 — the group’s innovative health division. He was named chief operating officer in January 2018 and CEO in January 2019, succeeding Ian Read. His entire corporate career has been spent at a single company.

The defining test arrived with COVID-19. Under Bourla, Pfizer partnered with BioNTech to develop an mRNA vaccine in under a year — a scientific and logistical feat that briefly pushed the company’s value past $300 billion and made Bourla a household name. Since then he has remade Pfizer into a more science-focused company: spinning off Upjohn into Viatris, combining consumer health with GSK, spending $43 billion on the cancer specialist Seagen in 2023, and pushing into obesity drugs with the acquisition of Metsera. In 2025 the company reported revenue of about $62.6 billion and internal R&D spending of $10.4 billion.

What Are Miguel Patricio and Albert Bourla Worth?

Neither man publishes a personal balance sheet, so their fortunes have to be pieced together from stock filings and compensation disclosures — and the honest answer is that the estimates vary.

For Patricio, the clearest window comes from insider-trading trackers. QuiverQuant estimates his net worth at a minimum of about $38.1 million, based on 561,817 Kraft Heinz shares he still holds and 901,416 shares he has sold since 2021 for roughly $34.2 million. His wealth is essentially the harvest of two decades at AB InBev and four years at the top of Kraft Heinz, converted into stock and cashed out over time.

Bourla’s numbers are harder to pin down because the estimates swing so widely. Lower-end trackers put him near $40 million; others, counting years of compounding Pfizer stock awards, run past $100 million. What is certain is the flow: he earned about $21 million in 2020, around $33 million in 2022, and $27.6 million in 2025 — a package built on a $1.8 million base salary, a $5.4 million bonus, and the rest in stock and option awards. He has sold millions of dollars of Pfizer stock over the years while retaining a large holding. Whichever estimate you prefer, his fortune was built the old-fashioned way for a lifer: salary, bonuses, and three decades of equity in one company.

Side by side, the comparison is striking. Patricio’s wealth came from moving between giants and cashing in; Bourla’s came from staying put and compounding. Both ended up in roughly the same place — the multi-tens-of-millions club that top-tier CEOs inhabit.

Are Miguel Patricio and Albert Bourla Related — or Even Connected?

This is the question that keeps the two names paired in search results, and the answer is straightforward: there is no reliable public evidence that they are related, and no record of them ever working together. Patricio is Portuguese and built his career in consumer goods and beverages; Bourla was born in Greece and built his in pharmaceuticals.

The reason their names appear together is circumstantial but real. Both became CEOs of major U.S.-listed companies in 2019 — Patricio at Kraft Heinz in July, Bourla at Pfizer in January — and both led household-name multinationals through the pandemic years. They surface side by side in executive rankings, CEO compensation studies, and leadership discussions. It is a coincidence of timing, not a partnership.

Family Life Beyond the Balance Sheet

Patricio guards his private life closely; almost nothing about his family has ever been made public — a fitting detail for a man who spent his career selling other people’s stories. What is known is professional: he stayed close to the 3G Capital circle that backed both AB InBev and Kraft Heinz, and he still represents AB InBev’s main shareholders on its board.

Bourla’s family story is better documented. He is married to Myriam Alchanati Bourla, and the couple has a son and a daughter. They live in Scarsdale, New York, and keep a home in Chalkidiki, Greece, where they spend their summers. Bourla left Greece at 34 and has since lived in seven cities across four countries — a rootlessness he shares, in a way, with Patricio, the Portuguese executive who built his life across continents. Both men still describe their birthplaces as home: Thessaloniki remains, in Bourla’s words, the “epicentre of his life.”

For more stories on the business figures shaping global brands, explore the celebrity coverage on Coachella Magazine.

Bottom Line

Miguel Patricio and Albert Bourla are a study in opposites who arrived at the same destination. One learned his trade selling soap, soda, cigarettes, and beer in half a dozen countries; the other learned his treating animals in Thessaloniki and stayed loyal to a single company for more than thirty years. One was hired to fix a broken food giant with marketing; the other was already inside the building when the pandemic made his company the most important drugmaker on earth.

Their shared billing in search results is an accident of the calendar — two men, two companies, one year. But the deeper connection is real enough: both prove that there is no single road to the corner office, only the long one, walked with unusual patience.

Are Miguel Patricio and Albert Bourla related?

No. There is no reliable public evidence that they are related or that they have ever worked together. They simply both became CEOs of major companies in 2019 and appear together in executive rankings.

What is Miguel Patricio’s net worth?

Insider-trading trackers estimate it at a minimum of about $38.1 million, based on his Kraft Heinz shareholdings and the roughly $34.2 million of shares he has sold since 2021. No official figure has been published.

What is Albert Bourla’s net worth?

Estimates vary widely, from roughly $40 million to over $100 million, depending on how his Pfizer stock holdings are valued. His disclosed compensation was $27.6 million in 2025.

Why did Miguel Patricio leave Kraft Heinz?

His departure was announced as a planned succession: Carlos Abrams-Rivera took over as CEO at the start of 2024. Patricio moved into the chair role and remained on the board; his chairmanship ended in December 2025.

Where was Albert Bourla born and educated?

He was born in Thessaloniki, Greece, in 1961 and earned his Doctor of Veterinary Medicine and Ph.D. in the Biotechnology of Reproduction at the Aristotle University of Thessaloniki.